|
|
|
Volumn 17, Issue 9 Suppl 8, 2003, Pages 16-19
|
|
Irinotecan and fixed-dose-rate gemcitabine in advanced pancreatic and biliary cancer: phase I study.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CAMPTOTHECIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
IRINOTECAN;
ADENOCARCINOMA;
ARTICLE;
BILIARY TRACT TUMOR;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
MALE;
METHODOLOGY;
PANCREAS TUMOR;
PHASE 1 CLINICAL TRIAL;
ADENOCARCINOMA;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BILIARY TRACT NEOPLASMS;
CAMPTOTHECIN;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MALE;
PANCREATIC NEOPLASMS;
RESEARCH DESIGN;
|
|
EID: 1542570577
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
